Moreover, the biomarkers identified in the present study, if validated in humans, may allow the identification and subsequent monitoring of individuals at early ages who are at greater risk of developing obesity and other pathologies, and whose alterations can be reverted by the intake of adequate amounts of leptin during lactation. The gene discussed is LEP; the disease is obesity disorder.